Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
openaccess
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision
Online Early
Online Early
Current Issue
Current Issue
Core Evidence
Vol. 2, No. 4
July, 2008
ISSN: 1555-1741
Free Trial
Free Trial
Sample Sample
Editorial
Editor-in-Chief
  Gulshan Sharma, MD
International editorial board
  Darren M. Ashcroft, Director, Centre for Innovation in Practice, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK
  Henry R. Black, Rush University Hypertension Center, Rush Presbyterian/St. Luke’s Medical Center, Chicago, IL, USA
  G. Walter Canonica, Professor, Allergy and Respiratory Diseases, DIMI, Department of Internal Medicine, University of Genoa, Genoa, Italy
  Stephen Chapman, Professor and Head, Keele's School of Pharmacy, University of Keele, Stafffordshire, UK
  Joshua P. Cohen, PhD, Tufts Center for the Study of Drug Development, Boston, MA, USA
  Sharon Conroy, Academic Division of Child Health, Derbyshire Children’s Hospital, Derby, UK
  Sanford I. Finkel, Department of Psychiatry and Behavioral Sciences University of Chicago Medical School, Chicago, IL, USA
  John A. Glaspy, Department of Medicine, UCLA School of Medicine, Los Angeles, California, USA
  Abraham G. Hartzema, Department of Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, FL, USA
  Joel W. Hay, Professor, Clinical Pharmacy and Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, CA, USA
  David M. Herrington, Professor of Internal Medicine-Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
  Stephen T. Holgate, Professor, Medicine, Health and Life Sciences, University of Southhampton, Southampton, UK
  Philip D. Home, Professor of Diabetes Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
  Robert H. Howland, University of Pittsburgh School of Medicine Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA
  Martin Knapp, Professor, London School of Economics and Political Science, London, UK
  Paul C. Langley, Adjunct Professor, Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, MN, USA
  Akira Matsuno, Professor of Neurosurgery, Director of Stroke Center, Vice-Director of Teikyo University Chiba Medical Center, Chiba, Japan
  Peter G.M. Mol, Department of Clinical Pharmacology, University Medical Centre Groningen, The Netherlands
  Robert P. Navarro, Navarro Pharma, LLC, Raleigh, North Carolina, USA
  Senaka Rajapakse, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Sri Lanka
  Olivier Rascol, Clinical Investigation Centre, Department of Clinical Pharmacology, Toulouse University Hospital, Toulouse, France
  Emilio J. Sanz, University of La Laguna School of Medicine, La Laguna, Tenerife, Spain
  David L. Scott, Professor, Academic Department of Rheumatology, King’s College London School of Medicine, Weston Education Centre, King’s College London, London, UK
  Ya-Chen Tina Shih, Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
  Dominic A. Sica, Professor of Medicine and Pharmacology, Virginia Commonwealth University, Richmond, VA, USA
  Andrea (Andy) Stergachis, Professor, Department of Epidemiology, University of Washington, Seattle, WA, USA
  Sean D. Sullivan, Director, Pharmaceutical Outcomes Research and Policy, Department of Pharmacy, University of Washington, Seattle, WA, USA
  Nicholas J. Talley, Professor, Department of Medicine and Epidemiology, Mayo Clinic, FL, USA
  Alan D. Tice, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA
  Tom Walley, Professor Biomedical Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
  Myron H. Weinberger, Director, Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
  Alberto Zanchetti, Professor, University of Milan, Milan, Italy
Peer reviewed
The editorial process combines clearly defined drug selection criteria, evidence-based medicine techniques, and expert clinical opinion, written in a format based on formulary requirements
Core Evidence is included in EMBASE, EMNursing, Scopus, the Health Economic Evaluations Database (HEED), and CINAHL. Indexing in all other major databases is being applied for